Skip to content
Research Article Open access CC BY 4.0

Prevalence of Hepatitis D Virus among People Attending the Antiretroviral Clinic and the Effect on the Liver Function Enzymes

Glory Barinuaka Baeka, Stephenson Danagogo Lawson, Sopriala Attoni Yeshua

Microbiology Research Journal International · pp. 63–70 · Published 31 Dec 2022

10.9734/mrji/2022/v32i11-121356

Abstract

Hepatitis D virus is an incomplete RNA virus requiring the assistance of the hepatitis B virus, specifically the HBsAg, to be infectious in humans. This study was designed to determine the prevalence of HDV among HIV patients and the effect on liver enzymes. The study was conducted at the Rivers state University Teaching hospital, Port Harcourt, Rivers State. Blood samples were obtained through vein puncture from 93 adults of which 41(44%) were males while 52(56%) were females between the ages 18 and 70 years attending the antiretroviral clinic and CD4+ cell count was also obtained. The samples were preserved at -20ºC.  Each of the samples was tested using a SWE-Care rapid strip (China) for the presence of HBsAg. HDV antibody was detected using a Dia. Pro ELISA kit (Italy). The AST, ALT and ALP were determined. SPSS 21 was used to analyze the data and P values were determined. From the total samples collected, 7(7.5%) of them were positive to the HBsAg test of which 3(3.2%) were males, while 4(4.3%) of them were females. Of the 7 people positive to the HBsAg, 6(6.4%) were positive to the HDV antibody with 3(3.2%) females and 3(3.2%) males. There was significant depletion of the CD4+ cells across the groups. For the liver function test, the P values were ˃ 0.05 for AST, ALT and ˂ 0.05 for ALP. The HDV infection from the study was not gender, nor age based and suggests a negative impact on the CD4 cells.  The liver function enzyme analysis, suggest higher risk of hypertension in HIV/HBV/HDV infection.

ALT ALP AST HBsAg HDV HIV

References (19)

  1. 1 EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [DOI]
  2. 2 ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries [DOI]
  3. 3 Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation [DOI]
  4. 4 Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view [DOI]
  5. 5 HIV Outcomes in Hepatitis B Virus Coinfected Individuals on HAART [DOI]
  6. 6 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel [DOI]
  7. 7 Epidemiology and clinical outcomes of hepatitis delta (D) virus infection in Queensland, Australia [DOI]
  8. 8 The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis [DOI]
  9. 9 The role of CD4 T cells in immune system activation and viral reproduction in a simple model for HIV infection [DOI]
  10. 10 Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria [DOI]
  11. 11 Underestimated Prevalence of HIV, Hepatitis B Virus (HBV), and Hepatitis D Virus (HDV) Triple Infection Globally: Systematic Review and Meta-analysis [DOI]
  12. 12 Hepatoprotective potentials of methanol extract of T. conophorum seeds of carbon tetrachloride induced liver damage in Wistar rats [DOI]
  13. 13 Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria [DOI]
  14. 14 Sources and clinical significance of aspartate aminotransferase increases in COVID-19 [DOI]
  15. 15 HBV and HIV Coinfections among Intending Blood Donors in Port Harcourt, Nigeria [DOI]
  16. 16 Hepatitis B in hepatocellular carcinoma patients and its correlation with alpha-fetoprotein and liver enzymes [DOI]
  17. 17 A novel and economic method to assess clinical transaminase assays [DOI]
  18. 18 Assessment of Biomarkers in Patients Co-Infected with HIV/HBV Attending the Antiretroviral Clinic in a Tertiary Institution [DOI]
  19. 19 Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda [DOI]

Cited by 1

Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009–2024

V. Adepoju, D. C. Udah, Qorinah Estiningtyas Sakilah Adnani · Viruses · 2024

Related research

Article metrics

Real usage data collected on this platform.

56

Page views

0

PDF downloads

12

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.